Myogenic tone is a fundamental aspect of vascular behavior in resistance arteries. This contractile response to changes in intravascular pressure is critically involved in blood flow autoregulation in tissues such as the brain, kidneys, and heart. Myogenic tone also helps regulate precapillary pressure and provides a level of background tone upon which vasodilator stimuli act to increase tissue perfusion when appropriate. Despite the importance of these processes in the brain, little is known about the mechanisms involved in control of myogenic tone in the cerebral microcirculation. Here, we report that pharmacological inhibition of P2Y4 and P2Y6 pyrimidine receptors nearly abolished myogenic tone in cerebral parenchymal arterioles (PAs). Molecular suppression of either P2Y4 or P2Y6 receptors using antisense oligodeoxynucleotides reduced myogenic tone by 44%±8% and 45% ± 7%, respectively. These results indicate that both receptor isoforms are activated by increased intravascular pressure, which enhances the activity of voltage-dependent calcium channels and increases myogenic tone in PAs. Enhancement or inhibition of ectonucleotidase activity had no effect on parenchymal arteriolar myogenic tone, indicating that this response is not mediated by local release of nucleotides, but rather may involve direct mechanical activation of P2Y receptors in the smooth muscle cells.
INTRODUCTION
While much is known about the mechanisms of myogenic regulation in pial arteries on the surface of the brain, 1-4 much less is known about this fundamental vascular response in arteries within the brain, the so-called parenchymal arterioles (PAs). The myogenic response is an important element of the brain's ability to autoregulate blood flow over a substantial range of intravascular pressures. Myogenic tone in the brain microcirculation also provides a background constricted state that is appropriate to control local perfusion pressure and protect capillaries from the potentially damaging effects of high intravascular pressure near the capillaries. Further, tonic constriction of cerebral arterioles contributes to the tightly regulated process of neurovascular coupling, whereby inhibition of such tone can lead to an appropriate increase in local blood flow when local neuronal activity increases. Nevertheless, the fundamental processes involved in myogenic response in the brain microcirculation have not been clarified. Given the specific environment in which the PAs reside and their unique interacting partners, that is, neruons, astrocytes, pericytes, etc., as well as other distinct functional aspects involving calcium signaling, 5, 6 ion channel function, 7 and tone development 8 in PAs versus the larger diameter pial arteries, it is reasonable to propose that the mechanisms of myogenic regulation in PAs may be unique as well.
A recent study involving heterologous expression of G-proteincoupled receptors (GPCRs) and TRPC6 channels as well as examination of myogenic mechanisms in brain pial and systemic arteries, lead to the interesting proposal that mechanical activation of Angiotensin II receptors in vascular smooth muscle cells is linked to myogenic tone development. 9 Although the mechanisms by which Angiotensin II receptors are actually mechanically activated were not defined in this study, linkage to activation of a depolarizing mechanism via PLC and DAG signaling was apparent. In light of these interesting observations, but given the unique behaviors of PAs versus pial arteries presented above, a major goal of the current study was to determine the contributions of GPCRs to the regulation of myogenic tone in the PAs. Our results indicate that, in cerebral parenchymal arterioles, GPCRs indeed mediate pressure-induced tone. However, we have found that P2Y4 and P2Y6 pyrimidine receptors, rather than Ang II receptors, are involved in this response. This behavior is likely produced by mechanoactivation of the pyrimidine GPCRs and does not appear to involve release of endogenous pyrimidine nucleotides or autocrine/paracrine activity.
MATERIALS AND METHODS

Animals and Tissues
Diameter Recordings
Endothelial cell-denuded arterial segments were mounted on glass pipettes in an arteriograph chamber (Living Systems, Burlington, VT, USA) containing a bicarbonate-buffered artificial cerebral spinal fluid (aCSF) of the following composition (in mmol/L): 136 NaCl, 3 KCl, 15 NaHCO 3 , 1.25 NaH 2 PO 4 , 1 MgCl 2 , 4 glucose, 2 CaCl 2 (temperature 37.51C and pH 7.3). The endothelium was removed by introducing an air bubble into the arterial lumen for 7.5 minutes followed by flushing with aCSF. Arteries were then pressurized to 10 mm Hg (with no flow), and superfused with warmed (371C), gassed (20% O 2 /5% CO 2 /balance N 2 ) aCSF. In experiments using Ca 2 þ -free aCSF, CaCl 2 was omitted, and 5 mmol/L EGTA was added. As an initial check of tissue viability and for verification of endothelial cell removal, arteries were constricted with the thromboxane receptor activator U46619 (100 nmol/L) and then exposed to 1 mmol/L NS 309, an activator of SK Ca and IK Ca channels which mediate endotheliumdependent vasodilator responses in these arteries. 11 Arteries were rejected for study if constrictions in response to U46619 were less than a 60% decrease in diameter. Absence of a dilation to NS 309 indicated successful endothelial cell removal. In experiments where steady myogenic tone was desired, pial arteries were pressurized to 80 mm Hg and PAs were pressurized to 40 mm Hg and studied after tone developed. In experiments where no myogenic tone was desired, for example, in studies of agonist-induced vasoconstriction, pial arteries, and PAs were pressurized to 10 and 5 mm Hg, respectively.
Oligonucleotides and Reversible Permeabilization
Antisense and sense oligodeoxynucleotides (ODNs) were designed based on published sequences for rat P2Y2 (RGD:62088), P2Y4 (RGD:61798), and P2Y6 (RGD:620269) receptors; the ODN sequences are shown in Supplementary Table 1 . The last five bases on the 5 0 and 3 0 ends were phosphorothioated to limit ODN degradation. All ODNs were synthesized by Integrated DNA Technologies Inc. (San Diego, CA, USA) Sense and antisense ODNs (2 mmol/L) were introduced into the arterial smooth muscle cells via a reversible permeabilization procedure. 3 The arterial segments were then organ cultured for 3 days in minimal essential medium (DMEM-F-12) with L-glutamine (2 mmol/L), penicillin (50 U/mL), and streptomycin (50 mg/mL) before use. Similar to studies on freshly isolated arteries, organ cultured arteries were rejected for further analysis if U46619 induced less than a 60% decrease in diameter.
RT-PCR for P2Y Receptor Message
RNA was prepared from isolated arterioles with endothelium present, as previously described for assay of ion channel message. 3 First-strand complementary DNA was prepared from 720 ng total RNA using the Qiagen (Valencia, CA, USA) Sensiscript Reverse Transcriptase kit. PCR was performed using HotStarTaq DNA Polymerase (Qiagen). PCR reactions were hot started at 941C for 10 minutes and exposed to 38 cycles of 941C for 60 seconds, 601C for 90 seconds, and 721C for 60 seconds, then followed by 721C final extension for 10 minutes. All reaction products were resolved on 1.8% agarose gels. Primer sequences are shown in Supplementary Table 2 .
Chemicals and Reagents
Buffer reagents, UTP and UDP were purchased from Sigma-Aldrich (St Louis, MO, USA). Nimodipine was dissolved in ethyl alcohol to a final solvent concentration of 0.1%. All other compounds were dissolved in the appropriate salt solution.
Statistical Analysis
Values are mean values ± s.e., and n indicates the number of animals. Arterial tone under different conditions is typically normalized as percentage Tone, and calculated as follows:
where 'Passive diameter' equals the diameter in Ca 2 þ -free aCSF.
For P2Y receptor agonist concentration/response relationships, responses are expressed as percent of the maximum contraction induced by the thromboxane receptor activator U46619. For P2Y receptor antagonist studies, data are expressed as percent inhibition of active tone.
Student's t-test was used to compare experimental groups. Mean values were considered significantly different at Pr0.05.
RESULTS
Angiotensin Receptor Inhibition Reduces Myogenic Tone in Pial Arteries, but not in Parenchymal Arterioles
The initial objective of the present study was to determine the possible contributions of Angiotensin II receptors to the mechanisms of myogenic tone in parenchymal arterioles. However, although we were able to confirm the involvement of these GPCRs in the myogenic behavior of pial arteries 9 ( Figure 1A ), we found no evidence of a similar role for angiotensin II receptors in isolated PAs ( Figure 1B) . Specifically, candesartan, an angiotensin II receptor blocker, had no effect on parenchymal arteriolar myogenic tone, a finding that was consistent with the absence of vasoconstrictor responses to angiotensin II itself in these arterioles ( Figure 1B ).
Inhibition of P2Y Receptors Inhibits Pyrimidine Nucleotide-Mediated Constrictions and Myogenic Tone in Isolated Parenchymal Arterioles
In view of the negligible angiotensin II receptor-mediated vasoconstriction of parenchymal arterioles, we next explored the possible contributions of other GPCRs in the myogenic behavior of these blood vessels. Pyrimidine nucleotides, in particular UTP and UDP, are known to cause substantial and sustained contraction of cerebrovascular smooth muscle [12] [13] [14] and previous evidence in mesenteric resistance arteries indicated that pyrimidine receptors may contribute to myogenic reactivity of systemic arteries. 15 Thus, we next considered the possible role of these receptors in parenchymal arteriolar myogenic behavior.
We first determined that message for the predominant vascular P2Y receptors (P2Y2, P2Y4, P2Y6) is present in parenchymal artery extracts. In agreement with previous studies examining localization of P2Y receptors in coronary 16 and pial 13 arteries, message for each of these receptors is present in PAs (Supplementary Figure 1 ). We subsequently explored the vasomotor activity of parenchymal arterioles in response to activation of P2Y receptors. Although a P2Y2-selective agonist (MRS 2768 17 ) had no effect on vascular tone in PAs (Figure 2A ), pyrimidine receptor ligands with relative affinities for P2Y2 and P2Y4 (UTPgS 18 ) or P2Y6 (MRS 2693 ¼ 5-iodo-UDP 19 ) receptors induced robust, dihydropyridinesensitive constrictions of isolated parenchymal arterioles without endothelium ( Figures 2B and 2C) . These studies suggested possible roles for P2Y4 or P2Y6 receptors in the constriction of PAs in response to extrinsic or intrinsic excitatory stimuli, mediated by calcium entry through voltage-dependent calcium channels (Ca V ), which is a hallmark of myogenic responses in most arteries.
To establish a possible link between P2Y receptor activity and myogenic tone in PAs, we next tested the effects of P2Y-receptor inhibition on the vasoconstrictor responses to P2Y4 and P2Y6 receptor ligands and on myogenic tone in PAs. Reactive Blue 2 (RB2, 10 mmol/L), which inhibits multiple P2 purinergic receptors, including P2Y4 and P2Y6 receptors (P2Y4 IC 50 : 19 mmol/L; 20 P2Y6 IC 50 : 1 mmol/L 21 ), substantially reduced constrictor responses to UTPgS or MRS 2693 ( Figures 3A and 3B) . Control experiments revealed no effect of RB2 on vasoconstriction induced by elevated bath K þ ( Figure 3C ) or by the thromboxane receptor activator U46619 ( Figure 3D ), indicating that the effects of RB2 are relatively selective for P2Y receptors. Interestingly, RB2 also inhibited pressure-induced myogenic tone in PAs (Figure 4) , with an IC 50 of 5.1 mmol/L (95% CI: 3.2 to 7.9 mmol/L). Supportive of a possible general role of P2Y receptors in regulation of cerebral myogenic tone, RB2 abolished the residual, candesartan-resistant myogenic tone in pial arteries (data not shown, n ¼ 3).
A substantial role for P2Y6 receptors in myogenic tone was further implied in studies using the relatively selective P2Y6 receptor blocker MRS 2578, which potently inhibited myogenic tone in PAs by a maximum of about 80% (Supplementary Figure 2 ). Selective pharmacological inhibitors of P2Y4 receptors are not available. Therefore, to corroborate and extend the previous observations, we next tested the effects of suppression of P2Y receptor expression on myogenic and pyrimidine nucleotideinduced tone.
Expression of P2Y4 and P2Y6 receptors was substantially reduced by antisense ODNs, as indicated by semiquantitative PCR (Figure 5A ). Parallel functional studies revealed that myogenic tone in PAs treated with antisense ODNs targeting P2Y4 or P2Y6 receptors was reduced by B50% compared with control (sensetreated) arterioles, as were responses to the respective P2Y4 or P2Y6 receptor ligands ( Figures 5B and 5C ). As predicted by the absence of P2Y2-mediated vasoconstrictor responses (Figure 2A ), P2Y2 receptor antisense treatment did not affect myogenic responses in PAs (data not shown).
Potentiation or Inhibition of Ectonucleotidase Activity has no Effect on Myogenic Tone in Parenchymal Arterioles
We next addressed the question whether the P2Y receptormediated activation underlying myogenic tone in PAs is due to the actions of endogenous pyrimidine nucleotides. If so, we predicted that enhanced ectonucleotidase activity by addition of exogenous ectonucleotidase enzyme (apyrase) should reduce myogenic tone and, conversely, inhibition of endogenous ectonucleotidase activity should increase myogenic tone. Figure 1 . Effects of the AT1 receptor inverse agonist candesartan on myogenic tone in cerebral arteries. (A) Candesartan inhibits myogenic tone and Ang II constricts pial arteries, but these Ang II receptor modulators have no significant effects on parenchymal arterioles (PAs) (B). (C) Grouped data show significant effect of cadesartan on pial artery myogenic tone and the absence of effect on myogenic tone in PAs. *Po0.05 versus response without candesartan. N ¼ 4 for pial and parenchymal artery groups. Pial arteries and PAs were pressurized to 80 and 40 mm Hg, respectively, to induce myogenic tone, and to 10 and 5 mm Hg, respectively, where myogenic tone is very low or absent, for assessment of Ang II-induced vasoconstrictions.
P2Y receptors regulate myogenic tone JE Brayden et al However, to the contrary, we found that exogenous ectonucleotidase activity sufficient to nearly abolish maximum UTP-or UDP-induced vasoconstrictions ( Figure 6A ), had no effect on parenchymal arteriolar myogenic tone. Similarly, inhibition of endogenous ectonucleotidase activity using ARL67156, such that constrictions to exogenous UTP were nearly tripled, did not alter myogenic tone in parenchymal arterioles ( Figure 6B ).
DISCUSSION
P2Y Pyrimidine Receptor Presence and Function in Parenchymal Arterioles
The present study provides the first evidence that P2Y pyrimidine receptors are critical regulators of intrinsic (myogenic) tone in cerebral parenchymal arterioles. There is considerable evidence for the presence of functional, pyrimidine nucleotide-sensitive receptors in the cerebral circulation. These receptors are wellrepresented in endothelial and vascular smooth muscle cells in the brain. Activation of cerebral endothelial P2Y receptors is uniformly associated with endothelium-dependent vasodilation; [22] [23] [24] this response is thought to be mediated primarily by P2Y1 and P2Y2 receptors located on the endothelial cells. 25, 26 The P2Y receptors that contribute to myogenic tone as shown in the present study are located on the cerebral vascular smooth muscle cells. P2Y6 receptors appear to be the predominant pyrimidine nucleotide receptors in cerebrovascular smooth muscle. 13, 27 However, P2Y4 receptors are also present in the vascular smooth muscle of cerebral arteries and these receptors can be selectively activated by pyrimidine nucleotide derivatives 27 . Effects of antisense oligonucleotides on P2Y receptor message levels, myogenic tone, and responses to P2Y4-and P2Y6specific ligands. (A) Semiquantitative PCR indicates a specific and substantial decrease in P2Y4-or P2Y6-message levels in arteries exposed to antisense versus sense oligodeoxynucleotides (ODNs) (sense or antisense ODN-treated parenchymal arterioles (PAs) from three animals were pooled in each case to assess relative message abundance). Myogenic tone and constrictions to receptor-specific ligands were significantly reduced in arterial samples treated with (B) P2Y4 (n ¼ 4 to 5) and (C) P2Y6 (n ¼ 8) receptor antisense ODNs. *Po0.05 versus sense-treated.
to cause vasoconstriction. P2Y4 receptors play a predominant role in the constrictor responses of rat intraparenchymal cerebral arterioles to UTP. 24 In the present study, we found that activation of P2Y4 or P2Y6, but not P2Y2 receptors, induced robust vasoconstriction that was abolished by block of voltagedependent Ca 2 þ channels in PAs. In arteries outside the brain circulation, pyrimidine receptor-mediated vasoconstriction is mediated primarily by calcium release from stores. 28 In cerebral arteries, calcium entry via Ca V channels is the major mechanism of P2Y receptor-induced constriction. 29, 30 This is consistent with the prevalence of Ca V -dependent constrictor responses in cerebral arteries in general. The responses of PAs to excitatory stimuli, including responses to other receptor ligands 31 as well as to increased intravascular pressure, 10, 31, 32 are particularly sensitive to Ca V channel inhibition.
P2Y4 and P2Y6 Receptors Mediate Myogenic Tone in Parenchymal Arterioles
A major finding in the present study is the central involvement of P2Y4 and P2Y6 pyrimidine nucleotide receptors in the mechanisms of myogenic tone in brain parenchymal arterioles. An initial goal of our study was to test the hypothesis that, similar to recent observations for pial arteries on the surface of the brain, 9 pressureinduced vascular tone of intraparenchymal arterioles is mediated by mechanoactivation of GPCRs. In the aforementioned study, pharmacological block of Angiotensin II receptors inhibited the myogenic responses of rat pial arteries by about 50%. This effect was proposed to be due to direct, physical activation of angiotensin II receptors, since inhibition of the formation of endogenous Angiotensin II by pretreatment of isolated pial arteries with an ACE inhibitor had no effect on myogenic tone development or the inhibitory effect of Angiotensin II receptor blockade. In the present study, we confirmed the potential contributions of angiotensin II receptors to the myogenic responses of isolated pial arteries. In PAs, however, we found no evidence for a role of angiotensin II receptors as mediators of myogenic tone. Our findings are in fact consistent with a role for GPCRs as mediators of myogenic tone, but in the case of the intraparenchymal arterioles P2Y4 and P2Y6 receptors are the key players. It is not clear why the particular receptors involved in the myogenic behavior of PAs should be different from those involved in the responses of pial arteries to increased intravascular pressure. This may be related in part to unique aspects of the environment and cellular interactions experienced by the PAs, specifically the associations among blood vessels, astrocytes, and neurons forming the so-called neurovascular unit.
There is abundant evidence in support of a role for signaling mechanisms downstream of GPCR activation in regulation of myogenic tone, in particular involving Gq/11 type receptors that signal through phospholipase C and reaction products derived from phosphatidylinositol. For instance, myogenic activation of canine renal arteries is correlated with elevated levels of IP3 and diacylglycerol. 33 More recent reports emphasize the significant involvement of IP3 receptors in myogenic tone. 34, 35 In addition, protein kinase C is clearly involved in the mechanisms underlying myogenic tone. 4, 36, 37 Although the contributions of the above PLC-related signaling pathways may vary among vascular beds, a common denominator of these signaling mechanisms is their ability to induce depolarization and activation of calcium entry through voltage-dependent calcium channels, 33, 36, 38 which as emphasized above, is a prime characteristic of myogenic tone in general. Pyrimidine receptor signaling is associated with activation of Gq/11 G-protein signaling 39 and therefore is a logical candidate mediator of the unique signaling mechanisms linking mechanical stimulation with vascular smooth muscle depolarization and contraction in cerebral parenchymal arterioles. The depolarization and constriction following activation of P2Y receptors in PA myocytes most likely involves several distinct mechanisms, including activation of transient receptor potential channels, 3 inhibition of K þ channels, 16 or through direct activation of CaV channels via mechanisms that involve PKC activity. 40 However, the relative contributions of these various mechanisms in PAs have not yet been resolved.
P2Y Receptors in Parenchymal Arterioles Are Activated by Mechanical Stimulation and not by Autocrine/Paracrine Mechanisms
The present results are consistent with the proposal that activation of P2Y receptors in the parenchymal arterioles is due to direct receptor mechanoactivation rather than via release of endogenous pyrimidine nucleotides from local sources. This proposal is based on the absence of effects on myogenic tone in the PAs when ectonucleotidase activity is either inhibited or potentiated. In contrast, myogenic tone is enhanced in mesenteric arteries isolated from ectonucleotidase null mice, 15 suggesting that endogenous pyrimidine nucleotides may modulate or directly stimulate myogenic responses in peripheral arteries. Explanations for the apparent differential contribution of endogenous pyrimidines to myogenic tone in peripheral arteries versus PAs are not obvious, but perhaps are consistent with the diverse nature of vascular structure and physiological control mechanisms in central versus peripheral blood vessels, ranging from endothelial permeability differences to fundamental differences in neurovascular regulatory function. A possible alternative explanation for the absence of effect of ectonucleotidase inhibition or activation on myogenic tone in the PAs is Figure 6 . Effects of exogenous ectonucleotidase (apyrase) and an ectonucleotidase inhibitor (ARL67156) on pyrimidine nucleotide-induced constrictions and myogenic tone in isolated parenchymal arterioles (PAs). (A) Apyrase inhibits responses to UTP and UDP but has no effect on myogenic tone (n ¼ 4). (B) The ectonucleotidase inhibitor ARL67156 enhances UTP-induced constrictions, but not myogenic tone (n ¼ 4). For UTP and UDP-induced responses, arteries were held at 5 mm Hg to minimize myogenic tone; myogenic tone was induced by increasing intravascular pressure to 60 mm Hg. *Po0.05 versus responses without apyrase or ARL67156.
insufficient penetration of compounds (apyrase, ARL67156) into sites of release and activity of endogenous pyrimidines. This possibility would seem unlikely for the ectonucleotidase inhibitor since it is a small molecule (MW:785 Da) that is capable of reaching sites of ectonucleotidase activity near pyrimidine receptors in sufficient amounts to greatly potentiate the action of exogenous pyrimidine nucleotides. Nevertheless, this issue would be most clearly resolved by direct measurement of endogenous pyrimidine nucleotide content and release during myogenic stimulation.
The physical interactions leading to mechanoactivation of P2Y receptors are not clear. Several models by which GPCRs could be mechanically activated have been proposed, including a tethered model whereby direct conformational changes of the receptor proteins within the cell membrane leads to receptor activation, as well as mechanisms involving receptor/cytoskeletal interactions that lead to receptor conformational changes (for review see ref. 41 ). There is evidence that both RB2 42 and the selective P2Y6 inhibitor MRS 2578 (ref. 43) can act as noncompetitive inhibitors of P2Y receptors. This suggests that through binding to sites on the receptor distinct from the natural ligand binding site, these inhibitors could have allosteric effects that inhibit receptor activity due to either the natural ligand binding or to the postulated mechanoactivation mechanisms associated with changes in intravascular pressure. Clarification of these issues will require further, detailed molecular and biophysical analysis.
Conclusions
The present results demonstrate that Gq/11-coupled P2Y4 and P2Y6 receptors contribute substantially to myogenic mechanisms of vasoconstriction in intraparenchymal cerebral arterioles. This response is mediated by mechanoactivation of the pyrimidine GPCRs and does not appear to involve release of endogenous pyrimidine nucleotides and autocrine/paracrine activity. A deeper appreciation of the specific signaling pathways and mechanisms involved in regulation of vascular tone within the brain may contribute to the development of novel approaches for treatment of brain microcirculatory disorders associated with stroke, hypertension, vasospasm, or other small vessel diseases.
